These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 26289732)
1. The economic impact of symptomatic menopause among low-socioeconomic women in the United States. Keshishian A; Wang Y; Xie L; Baser O Expert Rev Pharmacoecon Outcomes Res; 2016; 16(2):305-13. PubMed ID: 26289732 [TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life and healthcare resource utilization in Taiwanese women with menopausal symptoms: a nation-wide survey. Shyu YK; Pan CH; Liu WM; Hsueh JY; Hsu CS; Tsai PS J Nurs Res; 2012 Sep; 20(3):208-18. PubMed ID: 22902980 [TBL] [Abstract][Full Text] [Related]
3. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain. Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204 [TBL] [Abstract][Full Text] [Related]
4. Burden of illness of hypertension among women using menopausal hormone therapy: a US perspective. Hawkins K; Mittapally R; Chang J; Nahum GG; Gricar J Curr Med Res Opin; 2010 Dec; 26(12):2823-32. PubMed ID: 21058896 [TBL] [Abstract][Full Text] [Related]
5. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI). Blümel JE; Chedraui P; Barón G; Benítez Z; Flores D; Espinoza MT; Gomez G; González E; Hernández L; Lima S; Martino M; Montaño A; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Robles C; Saavedra J; Sánchez H; Tserotas K; Vallejo MS; Vallejo C; Climacteric; 2014 Aug; 17(4):433-41. PubMed ID: 24443950 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Healthcare Costs for Women with Treated Versus Untreated Vasomotor Symptoms Due to Menopause. Shiozawa A; Mancuso S; Young C; Friderici J; Tran S; Trenz HM Adv Ther; 2024 May; 41(5):1885-1895. PubMed ID: 38467985 [TBL] [Abstract][Full Text] [Related]
7. Roflumilast: Who Is Using It and How It Affects Health Care Resource Utilization and Costs. Jain R; Cai Q; Sun SX; Tan H Manag Care; 2015 Aug; 24(8):40-8. PubMed ID: 26399141 [TBL] [Abstract][Full Text] [Related]
8. [Risks, benefits and costs of hormone replacement therapy in menopause]. Gaspard U Rev Med Liege; 1998 May; 53(5):298-304. PubMed ID: 9689887 [TBL] [Abstract][Full Text] [Related]
9. Demographic characteristics and medical aspects of menopausal women in Taiwan. Chow SN; Huang CC; Lee YT J Formos Med Assoc; 1997 Oct; 96(10):806-11. PubMed ID: 9343980 [TBL] [Abstract][Full Text] [Related]
10. Treatment patterns, healthcare resource utilization and costs in patients with bipolar disorder, newly treated with extended release or immediate release quetiapine fumarate using US healthcare administrative claims data. Locklear JC; Alemayehu B; Brody RS; Chavoshi S; Tunceli O; Kern D; Earley WR Clin Ther; 2013 Dec; 35(12):1923-32. PubMed ID: 24275622 [TBL] [Abstract][Full Text] [Related]
11. The impact of menopausal symptoms on quality of life, productivity, and economic outcomes. Whiteley J; DiBonaventura Md; Wagner JS; Alvir J; Shah S J Womens Health (Larchmt); 2013 Nov; 22(11):983-90. PubMed ID: 24083674 [TBL] [Abstract][Full Text] [Related]
12. Low use of effective and safe therapies for moderate to severe menopausal symptoms: a cross-sectional community study of Australian women. Worsley R; Bell RJ; Gartoulla P; Davis SR Menopause; 2016 Jan; 23(1):11-7. PubMed ID: 26240945 [TBL] [Abstract][Full Text] [Related]
13. Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan. Huang WF; Tsai YW; Hsiao FY; Liu WC BMC Public Health; 2007 Apr; 7():56. PubMed ID: 17439639 [TBL] [Abstract][Full Text] [Related]
14. The impact of hormone replacement therapy on quality of life and willingness to pay. Zethraeus N; Johannesson M; Henriksson P; Strand RT Br J Obstet Gynaecol; 1997 Oct; 104(10):1191-5. PubMed ID: 9332999 [TBL] [Abstract][Full Text] [Related]
15. Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry. Baser O; Wei W; Henk HJ; Teitelbaum A; Xie L Curr Med Res Opin; 2012 Mar; 28(3):419-28. PubMed ID: 22364568 [TBL] [Abstract][Full Text] [Related]
16. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Utian WH Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502 [TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS). Glaser R; York AE; Dimitrakakis C Maturitas; 2011 Apr; 68(4):355-61. PubMed ID: 21177051 [TBL] [Abstract][Full Text] [Related]
18. COPD exacerbation frequency and its association with health care resource utilization and costs. Dhamane AD; Moretz C; Zhou Y; Burslem K; Saverno K; Jain G; Renda A; Kaila S Int J Chron Obstruct Pulmon Dis; 2015; 10():2609-18. PubMed ID: 26664109 [TBL] [Abstract][Full Text] [Related]